THE National Institute for Health and Care Excellence has revealed details of how it intends to assess the value of a medicine. NICE was charged with assessing the value of medicines under the Department of Health's planned value-based pricing system last year (PJ 2013;290:363). The system was due to come into effect this month, but now looks set to be introduced towards the end of 2014. Subject to public consultation next month, NICE intends to incorporate an assessment of a medicine's "value" into its technology appraisals by considering burden of illness and wider societal impact.
展开▼
机译：美国国家健康与护理卓越研究所（National Institute for Health and Care Excellence）已透露其打算如何评估药物价值的细节。去年，NICE负责根据卫生部计划的基于价值的定价系统评估药品的价值（PJ 2013; 290：363）。该系统原定于本月生效，但现在看来定于2014年底引入。要在下个月进行公众咨询，NICE打算通过考虑负担来将对药物“价值”的评估纳入其技术评估中疾病和更广泛的社会影响。
展开▼
